Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 7/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | FABP3 | P05413 | 7/20 | 0.52 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.48 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetramethylammonium Ion SCHEMBL8438225 | 1.00 | BBOX1 (0.56) | BBOX1CA1FABP3FFAR3HDAC3 | |
| Adipic Acid SCHEMBL106656 | 0.97 | BBOX1 (0.58) | BBOX1CA1FABP3FFAR3HDAC3 | |
| Adipic Acid SCHEMBL8028995 | 0.94 | BBOX1 (0.56) | BBOX1CA1FABP3FFAR3HDAC3 | |
| Glutarate SCHEMBL104188 | 0.91 | BBOX1 (0.58) | BBOX1CA1FABP3FFAR3HDAC3 | |
| Tetramethylammonium Ion SCHEMBL23754606 | 0.90 | BBOX1 (0.48) | BBOX1CA1FABP3 | |
| Myristic Acid SCHEMBL5154017 | 0.90 | FABP3 (0.67) | BBOX1CA1FABP3 | |
| Dodecanoate SCHEMBL5153809 | 0.90 | FABP3 (0.67) | BBOX1CA1FABP3 | |
| Heptadecanoic Acid SCHEMBL7549840 | 0.90 | FABP3 (0.67) | BBOX1CA1FABP3 | |
| Stearic Acid SCHEMBL109193 | 0.90 | FABP3 (0.67) | BBOX1CA1FABP3 | |
| Sebacic Acid SCHEMBL5874508 | 0.90 | TSHR (0.57) | BBOX1FABP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4269396-B1 | COMPOUND, CORROSION INHIBITOR, AND LUBRICANT COMPOSITION | IDEMITSU KOSAN CO (JP) | 2025-05-14 | — | — | EP | disclosed |
| US-20240124407-A1 | COMPOUND, CORROSION INHIBITOR, AND LUBRICANT COMPOSITION | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-04-18 | — | — | US | disclosed |
| EP-4269396-A1 | COMPOUND, CORROSION INHIBITOR, AND LUBRICANT COMPOSITION | Idemitsu Kosan Co., Ltd. (JP) | 2023-11-01 | — | — | EP | disclosed |
| US-7128976-B2 | Composition for film formation, method of film formation, and silica-based film | JSR CORPORATION (JP) | 2006-10-31 | — | — | US | disclosed |
| US-20030091838-A1 | Composition for film formation, method of film formation, and silica-based film | JSR CORPORATION (JP) | 2003-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240124407-A1 | COMPOUND, CORROSION INHIBITOR, AND LUBRICANT COMPOSITION | RB1, F12, CDKN1A | BBOX1 1189/4885CA1 192/4885FABP3 4885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.